- Home
- Primary Care
- Efficacy and Safety of Ustekinumab in Ulcerative Colitis: Insights from the UNIFI Phase 3 Program

1w3 min read
Medical Article
Introduction Ulcerative colitis (UC) is a chronic inflammatory condition of the large intestine, often requiring long-term immunosuppressive therapy. Existing treatments, including corticosteroids, immunomodulators, and TNF antagonists, are limited by adverse effects such as increased infection or cancer risk and loss of therapeutic response. Ustek

Efficacy and Safety of Ustekinumab in Ulcerative Colitis: Insights from the UNIFI Phase 3 Program
22 Reached
Similar Content

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Single-incision Laparoscopy for Gastrostomy
407 Reached2 Comments1 Likes

Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments

Intestinal Obstruction and Ileocolic Fistula due to Gossypiboma
861 Reached30 Comments15 Likes